Benjamin Shapiro Oramed Pharmaceuticals Inc. (ORMP) insider trading activity
Benjamin Shapiro is Director of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 55,070 shares of ORMP, which is worth approximately $124,458. The most recent transaction as insider was on Jan 04, 2024, when has been sold 35,070 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
55.1K
0%
3M change
175.35%
12M change
Total Value Held
$124,458
BS
Benjamin Shapiro
Director
New York, NY